New Milestone within the Protinus-Project

PHARMAPLAN(Switzerland)-TTP Group / Basel, 22.Juli 2020: To meet the high demand for immunoglobulin (Privigen®), CSL Behring is expanding produc-tion capacities at the Bern/Wankdorf site in cooperation with Pharmaplan as gen-eral planner. Another milestone was reached in June: The start of the process qualification of module V within the Protinus project.

By definition, this is a “brownfield” project for two new process modules for the production of immunoglobulin products made from blood plasma (Privigen®).

Located in the heart of the site in Bern, the new process building will border existing buildings or property boundaries on all sides and will and will integrate the existing logistics building into the Wankdorf site through old and new pedes-trian bridges and entrances. The logistics building will be jacketed, newly roofed and extended by the new building. The scope of the project also includes the project realization without disrupting ongoing operations.

At the beginning of February 2017, the “Go” for the basic design with Pharmaplan in the role as general planner was given. In late summer 2018, Pharmaplan then took additional responsibility for the entire construction site with the leadership of construction management and now is managing the commissioning and qual-ification phase.

During the construction phase, which has now lasted 18 months, a smooth transport of materials to and from the site was ensured. Through the commit-ment of all those involved, unexpected challenges were accomplished like a groundwater ingress and a rainwater flash flood. Up to 100 companies and 300 workers on the construction site were coordinated and the thoughtful behavior of all those involved ensured the safety on the construction site, which is re-flected in brilliant safety statistics not only in Swiss rankings but also in the global comparison.

Despite the Corona crisis, all milestones were met in the project. This will ena-ble CSL Behring to ensure the supply of Privigen® in the future. We would like to thank CSL Behring for the successful project, the high level of technical ex-pertise and the excellent cooperation.

The video gives unique insights into this highly sophisticated production facility. Copyright © 2020 CSL Behring AG

About the TTP Group: The TTP Group is a group of companies specialized in engineering services for the process industry. Since 2019, the management company TTP GmbH has united the TRIPLAN and PHARMAPLAN companies under one roof. This makes the TTP Group one of the leading medium-sized engineering companies for the process industry in Europe. More than 900 employees are working at over 20 locations in Belgium, Germany, France, Switzerland and India.

PHARMAPLAN is a valued engineering partner of the European pharmaceutical industry and covers the entire range of engineering services – from feasibility and concept studies to the implementation of investment projects (EPCMV) and on-site support in operational engineering.

Under the operational brand TRIPLAN, TTP offers engineering services for plant construction primarily in the chemical and petroche-mical industries. As an independent general and component planner, TRIPLAN takes over the technical development for new construc-tion projects, conversion projects and the modernisation and optimisation of existing plants.

Media Contact (CH)
PHARMAPLAN Schweiz
Sara Sleiman
Communications Manager

Tel.: +41 61 307 9670
Mobil: +41 79 124 7527
Sara.Sleiman@pharmaplan.com

Media Contact (D)
TTP Group Deutschland
Iris Huber
Manager Corporate
Marketing & Communications

Tel.: +49 8031 28 200 116
Mobil: +49 175 19 254 96
Iris.Huber@ttp-group.eu